Larry Biegelsen
Stock Analyst at Wells Fargo
(3.92)
# 522
Out of 4,832 analysts
306
Total ratings
54.71%
Success rate
7.54%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HYPR Hyperfine | Maintains: Equal-Weight | $1.29 → $0.68 | $0.60 | +13.52% | 5 | May 14, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $113 → $98 | $96.47 | +1.59% | 10 | May 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $195 → $174 | $152.77 | +13.90% | 12 | May 6, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $146 → $137 | $125.89 | +8.83% | 5 | May 2, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $36 → $33 | $30.91 | +6.76% | 16 | May 2, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $15 → $12 | $11.67 | +2.83% | 6 | May 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $103 → $89 | $72.93 | +22.03% | 4 | May 1, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $22 → $20 | $22.81 | -12.30% | 9 | May 1, 2025 | |
| GKOS Glaukos | Downgrades: Equal-Weight | $160 → $86 | $91.83 | -6.35% | 14 | May 1, 2025 | |
| PEN Penumbra | Maintains: Overweight | $305 → $315 | $272.76 | +15.49% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $22 → $17 | $13.39 | +26.96% | 12 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $28 | $23.38 | +19.76% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $117 | $97.71 | +19.75% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $118 | $104.95 | +12.43% | 13 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $17.04 | -0.23% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $427 → $435 | $391.97 | +10.98% | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $630 → $687 | $561.65 | +22.32% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $149.10 | +1.95% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $3.31 | +141.69% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $85.66 | +9.74% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $118 | $81.29 | +45.16% | 16 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $106 → $98 | $85.78 | +14.25% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $80 | $76.80 | +4.17% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $105 | $87.67 | +19.77% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $40 | $17.41 | +129.75% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $12.89 | +280.14% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $133.07 | +2.20% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $58.00 | +20.69% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $171.76 | +57.20% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $79.95 | - | 2 | Nov 2, 2017 |
Hyperfine
May 14, 2025
Maintains: Equal-Weight
Price Target: $1.29 → $0.68
Current: $0.60
Upside: +13.52%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $96.47
Upside: +1.59%
Inspire Medical Systems
May 6, 2025
Maintains: Equal-Weight
Price Target: $195 → $174
Current: $152.77
Upside: +13.90%
Teleflex
May 2, 2025
Maintains: Equal-Weight
Price Target: $146 → $137
Current: $125.89
Upside: +8.83%
Baxter International
May 2, 2025
Maintains: Equal-Weight
Price Target: $36 → $33
Current: $30.91
Upside: +6.76%
Bausch + Lomb
May 1, 2025
Maintains: Equal-Weight
Price Target: $15 → $12
Current: $11.67
Upside: +2.83%
GE HealthCare Technologies
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $72.93
Upside: +22.03%
Tandem Diabetes Care
May 1, 2025
Maintains: Equal-Weight
Price Target: $22 → $20
Current: $22.81
Upside: -12.30%
Glaukos
May 1, 2025
Downgrades: Equal-Weight
Price Target: $160 → $86
Current: $91.83
Upside: -6.35%
Penumbra
Apr 24, 2025
Maintains: Overweight
Price Target: $305 → $315
Current: $272.76
Upside: +15.49%
Apr 7, 2025
Maintains: Equal-Weight
Price Target: $22 → $17
Current: $13.39
Upside: +26.96%
Mar 31, 2025
Initiates: Overweight
Price Target: $28
Current: $23.38
Upside: +19.76%
Feb 26, 2025
Maintains: Overweight
Price Target: $120 → $117
Current: $97.71
Upside: +19.75%
Feb 6, 2025
Maintains: Overweight
Price Target: $100 → $118
Current: $104.95
Upside: +12.43%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $17.04
Upside: -0.23%
Jan 29, 2025
Maintains: Overweight
Price Target: $427 → $435
Current: $391.97
Upside: +10.98%
Jan 24, 2025
Maintains: Overweight
Price Target: $630 → $687
Current: $561.65
Upside: +22.32%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $149.10
Upside: +1.95%
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $3.31
Upside: +141.69%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $85.66
Upside: +9.74%
Dec 6, 2024
Maintains: Overweight
Price Target: $115 → $118
Current: $81.29
Upside: +45.16%
Nov 20, 2024
Maintains: Overweight
Price Target: $106 → $98
Current: $85.78
Upside: +14.25%
Sep 9, 2024
Maintains: Overweight
Price Target: $90 → $80
Current: $76.80
Upside: +4.17%
Aug 22, 2024
Maintains: Overweight
Price Target: $94 → $105
Current: $87.67
Upside: +19.77%
Jul 26, 2024
Maintains: Overweight
Price Target: $42 → $40
Current: $17.41
Upside: +129.75%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $12.89
Upside: +280.14%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $133.07
Upside: +2.20%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $58.00
Upside: +20.69%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $171.76
Upside: +57.20%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $79.95
Upside: -